Up
2006P-0348:
Amend the Vancomycin HCl Package Insert to Reflect Modifications
of the Antimicrobial Susceptibility Interpretive Criteria to Better
Recognize Emerging Resistance Resulting in Compromised Patient Outcomes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
CP1 |
|
08/23/2006
|
|
08/24/2006
|
|
Private Industry
|
|
Clinical and
Laboratory Standards Institute |
|
|
|
|
|
|
|
pdf
Attachments
|
|
|
|
|
Signature: |
|
Robert Habig, PhD and Glen
Fine, MS |
|
|
|
ACK1 |
|
08/24/2006
|
|
08/24/2006
|
|
Federal Government |
|
FDA/DDM to
Clinical and Laboratory Standards Institute |
|
|
|
|
|
|
|
pdf |
|
|
|
|
Signature: |
|
Lyle D. Jaffe |
|
|
|
EC1 |
|
08/31/2006
|
|
08/31/2006
|
|
Individual Consumer
|
|
Mr. Dave Lowe |
|
|
|
|
|
|
|
htm |
|
|
|
|
|
C1 |
|
09/14/2006
|
|
09/11/2006
|
|
Health Care
Association |
|
Society of
Infectious Diseases Pharmacists (SIDP) |
|
|
|
|
|
|
|
pdf |
|
|
|
|
Signature: |
|
THomas C. Hardin, PharmD.,
MBA, FC |
|
|
|
EC2 |
|
09/15/2006
|
|
09/14/2006
|
|
Health Care
Association |
|
Infectious Diseases
Society of America |
|
|
|
|
|
|
|
pdf |
|
|
|
|
|
|
Signature: |
|
Blaser, Martin |
|
|
|
EC3 |
|
09/18/2006
|
|
09/17/2006
|
|
Individual Consumer
|
|
Mr. Dave Lowe
|
|
|
|
|
|
|
|
htm
Attachment |
|
|
|
|
|
EC4 |
|
09/19/2006
|
|
09/18/2006
|
|
Health Care
Association |
|
Infectious Diseases
Society of America |
|
|
|
|
|
|
|
pdf |
|
|
|
|
|
|
Signature: |
|
Blaser, Martin J.
|
|
Top | Up
Page last updated
October 18, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |